title: Granuloma faciale treated with topical dapsone: a case report.
abstract: Granuloma faciale (GF) is an unusual, treatment-resistant skin disorder that commonly affects the face. Several medical and surgical interventions are available that offer varying degrees of benefit. Both the condition and the treatment modalities can lead to significant disfigurement. The use of oral dapsone in the treatment of GF has been described in the literature, but there are no reports, to our knowledge, of the use of topical dapsone 5% gel (Aczone; Allergan Inc, Irvine, CA). We present a case of a patient with GF on the nasal tip successfully treated with topical dapsone.
authors.forename: Olubukola
authors.initials: O
authors.lastname: Babalola
authors.forename: Jessica
authors.initials: J
authors.lastname: Zhang
authors.forename: Arni
authors.initials: A
authors.lastname: Kristjansson
authors.forename: Diane
authors.initials: D
authors.lastname: Whitaker-Worth
authors.affiliation: University of Connecticut School of Medicine.
authors.forename: Meagen
authors.initials: M
authors.lastname: McCusker
mesh_terms: D000279:Administration, Cutaneous; D000890:Anti-Infective Agents / Q000008:administration & dosage; D001706:Biopsy; D003622:Dapsone / Q000008:administration & dosage*; D003937:Diagnosis, Differential; D005148:Facial Dermatoses / Q000188:drug therapy* / Q000473:pathology; D006099:Granuloma / Q000188:drug therapy* / Q000473:pathology / Q000517:prevention & control; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D000890:Anti-Infective Agents; D003622:Dapsone